Combination of Danggui Buxue Tang and concurrent chemoradiotherapy improves treatment outcomes by strengthening B cell immunity in patients with nasopharyngeal carcinoma—a double-blind, randomized trial
- DOI
- 10.21037/tcr-2025-406
- Published
- 2025-09
- Container
- Translational Cancer Research
- Publisher
- AME Publishing Company
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.21037/tcr-2025-406,
title = {Combination of Danggui Buxue Tang and concurrent chemoradiotherapy improves treatment outcomes by strengthening B cell immunity in patients with nasopharyngeal carcinoma—a double-blind, randomized trial},
author = {He-Yuan Hsieh and Shih-Neng Yang and Ming-Yu Lien and Yao-Ching Wang and Chia-Hao Chang and Han-Kuei Wu and Yu-Cheng Hsu and Ching-Yun Hsieh and Yu-Chuen Huang and Hen-Hong Chang},
year = {2025},
journal = {Translational Cancer Research},
doi = {10.21037/tcr-2025-406},
url = {https://doi.org/10.21037/tcr-2025-406}
}RIS
TY - JOUR TI - Combination of Danggui Buxue Tang and concurrent chemoradiotherapy improves treatment outcomes by strengthening B cell immunity in patients with nasopharyngeal carcinoma—a double-blind, randomized trial AU - He-Yuan Hsieh AU - Shih-Neng Yang AU - Ming-Yu Lien AU - Yao-Ching Wang AU - Chia-Hao Chang AU - Han-Kuei Wu AU - Yu-Cheng Hsu AU - Ching-Yun Hsieh AU - Yu-Chuen Huang AU - Hen-Hong Chang PY - 2025 JO - Translational Cancer Research DO - 10.21037/tcr-2025-406 UR - https://doi.org/10.21037/tcr-2025-406 ER -
APA
Hsieh, H., Yang, S., Lien, M., Wang, Y., Chang, C., Wu, H., Hsu, Y., Hsieh, C., Huang, Y., & Chang, H. (2025). Combination of Danggui Buxue Tang and concurrent chemoradiotherapy improves treatment outcomes by strengthening B cell immunity in patients with nasopharyngeal carcinoma—a double-blind, randomized trial. Translational Cancer Research. https://doi.org/10.21037/tcr-2025-406
Source records
- crossref · retrieved 2026-09-25T08:52:24.939Z